Reminyl, Amaryl Name Confusion Concerns ISMP

Confusion between the antidiabetic Amaryl and the Alzheimer’s medication Reminyl has resulted in medication errors, the Institute for Safe Medication Practices says. ISMP is working with FDA, Aventis and Janssen to develop a solution.

More from Archive

More from Pink Sheet